Paradigm BioCapital Advisors LP 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:41 pm Purchase |
2024-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Paradigm BioCapital Advisors LP | 3,515,986 6.000% |
907,412 (+34.79%) |
Filing |
| 2024-10-23 5:39 pm Purchase |
2024-10-16 | 13G | Janux Therapeutics, Inc. JANX |
Paradigm BioCapital Advisors LP | 2,608,574 5.000% |
2,608,574 (New Position) |
Filing |